|
Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us] DOCKETS ENTERED on April 2, 2002 TABLE OF CONTENTS Hyper links are part of the Docket title - not all dockets/documents are linked NOTE: Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence. |
|
77N-0085 Saccharin and Its Salts
CA 35618 Number not used Vol#: 588
CA 35813 Mario F Gregory Vol#: 590
CA 35925 Malcom W Hoag Vol#: 592
CA 36043 House of Representatives Vol#: 593
93D-0398 Microbiological Testing Antimicrobial Drug Residues in Foods
C 7 American Society for Microbiology Vol#: 1
94F-0405 Safe use of aspartame as general purpose sweetener
EMC 156 Scott Dykstra Vol#: 4
EMC 157 Carmela Quail Vol#: 4
EMC 158 Brady McElligott Vol#: 4
EMC 159 Charmelle Vol#: 4
EMC 160 Betty Martini Vol#: 4
EMC 161 D. C. Kern Vol#: 4
EMC 162 Betty Martini Vol#: 4
EMC 163 D. C. Kern Vol#: 4
EMC 164 Michael Tordoff Vol#: 4
EMC 165 Betty Martini Vol#: 4
EMC 166 Nesie M. Nichols Vol#: 4
95S-0117 Human Drugs Patent Term Extension & New Patents
LST 72 List as of March 20, 2002 Vol#: 4
98D-0266 Section 121 Positron Emission Tomography (PET) FDAMA
GDL 1 Draft Guidance Vol#: 11
NAD 1 Draft Guidance Vol#: 11
98D-0314 Pilot Program for eIND Applications for Biological Products
GDL 2 GUIDANCE Vol#: 1
NAD 2 Vol#: 1
98P-0151 Introduction Of Downed Cattle Into The Food Supply
C 5707 R. Reichert Vol#: 233
C 5708 Jean Bowen Vol#: 233
C 5709 Larry Carradine Vol#: 233
C 5710 Marilyn Weaver Vol#: 233
C 5711 Diane Lee Schmidt Vol#: 233
C 5712 Reginald F. Lindley Vol#: 233
C 5713 Patricia A. Lindley Vol#: 233
C 5714 Deborah S. Lindley Vol#: 233
C 5715 Ben Hale Vol#: 233
C 5716 Connie Holt Vol#: 233
99N-4063 Positron emmission tomography drug products
BKG 2 Background Material Vol#:
NAD 2 Vol#: 1
01N-0301 Agency Information Collection; Customer/Partner Ser Surveys
NAL 1 Vol#: 1
SS 1 SUPPORTING STATEMENT Vol#: 1
01N-0402 Third-Party Submissions review/quality system inspections
NAL 1 Vol#: 1
SS 1 SUPPORTING STATEMENT Vol#: 1
02D-0095 Exposure-Response Relaionship;Study Design,Data Analysis
GDL 1 GUIDANCE Vol#: 1
NAD 1 Vol#: 1
02D-0103 Revised Male Condom Defects
GDL 1 GUIDANCE Vol#: 1
NAD 1 Vol#: 1
02N-0054 Labeling Requirements for Color Additives
N 2 Vol#: 1
02N-0104 Consumer Handling of Ready-To-Eat Foods
N 1 Vol#: 1
02P-0139 Arava (leflunomide;Aventis) remove from the market
02P-0141 ANDA for 1.2 mg estropipate (1.2 mg sodium estrone sulfate)